The Clinical TMS Society is an influential organization dedicated to advancing the understanding and application of Transcranial Magnetic Stimulation (TMS) therapy. TMS is a non-invasive outpatient treatment that utilizes magnetic fields to stimulate nerve cells in the brain, primarily targeting conditions such as depression and obsessive-compulsive disorder (OCD). Since receiving FDA clearance in 2008 for depression and in 2018 for OCD, TMS has demonstrated its efficacy in improving mental health outcomes, with significant response rates among patients resistant to traditional antidepressants.

The Clinical TMS Society not only educates patients and families about the benefits and protocols of TMS therapy but also provides resources for clinicians to enhance their practice. They emphasize the safety and tolerability of TMS, noting that treatments typically occur over several weeks, require no anesthesia, and allow patients to resume daily activities immediately after sessions. The society also explores TMS’s potential for a variety of other neurological and psychiatric conditions, making it a prominent advocate for innovative mental health treatments